Aurobindo Pharma Buyback 2024 Record Date, How Many Shares Does Aurobindo Pharma Plan To Buy Back?

Aurobindo Pharma Buyback 2024 Record Date

The record date for Aurobindo Pharma's 2024 share buyback is set for July 30, 2024. This is the date on which the company will determine which shareholders are eligible to participate in the buyback. If you own shares of Aurobindo Pharma on or before this date, you will be eligible to sell your shares back to the company at Rs 1,460 per share. 

The company aims to buy back up to 51.36 lakh shares, with a total buyback amount of up to Rs 750 crore. This move is designed to return capital to shareholders and may impact the company's future growth and investment strategies.

How Many Shares Does Aurobindo Pharma Plan To Buy Back?

Aurobindo Pharma plans to buy back up to 51.36 lakh (5.136 million) of its equity shares. This buyback represents 0.88% of the company's total shares. 

The buyback will be done at a price of ₹1,460 per share. The goal of this buyback is to return capital to shareholders and is the company's first-ever share buyback.

What Percentage Of Aurobindo Pharma's Shares Do The Promoters Hold?

As of the latest update, the promoters of Aurobindo Pharma hold 51.8% of the company's shares. This means that just over half of the company's total shares are owned by its promoters, who are the major shareholders and typically include the founders and key executives of the company. 

This significant stake indicates that the promoters have substantial control and influence over the company's decisions and direction. In addition to the promoters, other shareholders include mutual funds with a 19.17% stake and foreign portfolio investors holding 16.73% of the shares.

Aurobindo Pharma 

Aurobindo Pharma is an Indian pharmaceutical company based in Hyderabad. It makes generic medicines and active ingredients for drugs. The company operates in several major areas, including antibiotics, anti-viral drugs, heart medications, and more. It sells its products in over 125 countries and partners with big names like AstraZeneca and Pfizer.

Founded in 1988, Aurobindo Pharma started by making penicillin. It became a public company in 1992 and has grown to be one of India's top pharmaceutical firms. It has expanded into Europe and plans to enter new markets and develop new products. Recently, it acquired several companies and signed agreements to boost its business further.

How to Participate in Aurobindo Pharma's 2024 Buyback?

Here's how to participate in Aurobindo Pharma's 2024 buyback:

• Hold shares of Aurobindo Pharma in Demat or physical form by the record date, July 30, 2024.
• When the buyback process opens (dates to be updated), sell your shares through your broker on NSE or BSE.
• On the payment date (to be updated), you'll get payment for the shares accepted in the buyback. Any unaccepted shares will be returned to your Demat account.